Which potassium citrate works best for kidney stones? new study aims to find out

NCT ID NCT06819111

First seen Feb 05, 2026 · Last updated Jun 22, 2026 · Updated 22 times

Summary

This study will test three different forms of potassium citrate—a medication that helps prevent kidney stones by making urine less acidic. Twenty adults who have had kidney stones will take each form for one week, with a week off in between. Researchers will measure changes in urine acidity and ask participants about side effects and preferences.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEPHROLITHIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Potassium citrate (slow-release tablet, powder, and tablet forms)

What this could lead to

If successful, this could show which form of potassium citrate works best and is most tolerable for preventing kidney stones.

What could go wrong

This is a small, early-phase study with only 20 participants, so results may not apply to everyone. It compares existing drugs, not a new breakthrough.

Conditions

The condition(s) this trial relates to.

Kidney Calculi nephrolithiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.